Area of research
Immunology · Oncology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, and Cancer Immunotherapy and Biomarkers.
Initial TCR Signal Strength Imprints GATA3 and Tbet Expression Driving T-helper Cell Fate Decisions
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
A T cell resilience model associated with response to immunotherapy in multiple tumor types
A T cell resilience model associated with response to immunotherapy in multiple tumor types.
STING agonist promotes CAR T cell trafficking and persistence in breast cancer
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade
T cell stemness and dysfunction in tumors are triggered by a common mechanism
T cell stemness and dysfunction in tumors are triggered by a common mechanism.
Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape
Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest